Funding Update
UFHCC + Extramural Opportunities
Extramural Opportunities
Please visit our website to find the complete and updated list of cancer-focused extramural funding opportunities or subscribe to UFHCC Opportunity to receive the weekly email.
Other Extramural
Pfizer
Current & Future Directions in CML
Application: 4/23/2019
Advances in the Management of Acute Leukemia
Application: 4/25/2019
Using Biosimilars in Oncology
Application: 4/30/2019
The Experimental Therapeutics Clinical Trials Network (UM1 Clinical Trial Required)
Application: 5/13/2019
NIH
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
Application: 9/28/2019
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
Application: 9/28/2019
Biology of Bladder Cancer (R01 Clinical Trial Optional)
Application: 5/8/2022
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
Application: 1/8/2022
Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required)
Application: 1/4/2022
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)
Application: 1/8/2022